STOCK TITAN

Lifeward (LFWD) Form 4: VP Sells Shares Under Automatic Sell-to-Cover

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lifeward Ltd. insider sale to cover taxes following RSU vesting. Jeannine Lynch, VP of Market Access & Strategy and a director, reported the sale of 1,591 ordinary shares on 09/02/2025 at $0.64 per share to satisfy tax withholding tied to RSUs that vested on 08/31/2025. After the sale she beneficially owns 46,067 ordinary shares indirectly, and the transaction was executed under an automatic sell-to-cover arrangement mandated by her RSU grant agreement. The filing states the sale was not a discretionary trade by the reporting person.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine sell-to-cover for tax withholding; standard insider reporting, no discretionary trading indicated.

The Form 4 documents a common administrative transaction where vested RSUs triggered a required sell-to-cover to remit taxes. The filing clarifies the sale was automatic under the RSU agreement and not a voluntary market disposition, which reduces governance or signaling concerns. The reporting person retains a significant indirect stake of 46,067 shares after the transaction, preserving alignment with shareholders. No governance red flags or deviations from plan terms are disclosed in the filing.

TL;DR: Small open-market sale for tax obligations; immaterial to company capitalization and not indicative of strategic divestment.

The disposition of 1,591 shares at $0.64 each appears solely to cover tax withholding on RSU vesting dated 08/31/2025. The amount sold is modest relative to the reported post-transaction beneficial ownership, suggesting limited market impact. The transaction was executed under an automatic arrangement and explicitly described as non-discretionary, which reduces its informational content for investors assessing insider sentiment. No additional derivative activity or broader equity changes are reported.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lynch Jeannine

(Last) (First) (Middle)
C/O LIFEWARD LTD.
200 DONALD LYNCH BLVD.

(Street)
MARLBOROUGH MA 01752

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP of Market Access & Strategy
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares, par value NIS 1.75 per share 09/02/2025 S 1,591(1) D $0.64 46,067 I ESOP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents Ordinary Shares sold in the open market on September 2, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 31, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan (the "Plan") on August 31, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.
Remarks:
The automatic sell-to-cover arrangement is mandated by the terms of the Company's RSU grant agreement, dated as of the Grant Date, by and between the Company and the Reporting Person with respect to the payment of taxes upon vesting of the RSUs.
/s/ Jeannine Lynch 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LFWD insider Jeannine Lynch report on Form 4?

She reported selling 1,591 ordinary shares on 09/02/2025 at $0.64 per share to cover taxes on vested RSUs.

Was the sale by the LFWD insider discretionary?

No. The filing states the shares were sold pursuant to an automatic sell-to-cover arrangement mandated by the RSU grant agreement.

How many LFWD shares does Jeannine Lynch beneficially own after the transaction?

Following the reported sale, she beneficially owns 46,067 ordinary shares (indirect).

Why were the shares sold according to the Form 4?

The shares were sold to satisfy the reporting person's tax withholding obligation arising from RSUs that vested on 08/31/2025.

Does the Form 4 show any options or derivative transactions for LFWD by this filer?

No. The filing lists only a non-derivative open-market sale tied to RSU tax withholding; no derivative securities are reported.
Lifeward Ltd

NASDAQ:LFWD

LFWD Rankings

LFWD Latest News

LFWD Latest SEC Filings

LFWD Stock Data

12.38M
17.95M
2.07%
2.89%
7.44%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Israel
MARLBOROUGH